Go
ASCO Guideline: Oxaliplatin Adjuvant Therapy for Stage III Colon Cancer May Be Reduced in Select Patients
CD40 Combination Therapy Can Shrink Pancreatic Tumors
Lynparza Delays Progression of BRCA-mutated Metastatic Pancreatic Cancer
FDA Approves Lonsurf® for Treatment of Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Lynparza significantly delayed disease progression as 1st-line maintenance treatment in germline BRCA-mutated metastatic pancreatic cancer
Keytruda Immunotherapy for Treatment of Liver Cancer
Laurie MacCaskill Partners with CancerConnect
FDA Approves Lenvatinib for Treatment of Advanced Hepatocellular Cancer
Cyramza Improves Survival in Poor-Prognosis Liver Cancer
mFOLFIRINOX Found Superior to Gemzar for Treatment Surgically Resected Pancreatic Cancer
FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults
« More News Tips & Features